237435-96-0 Usage
Uses
Ethyl 3-amino-5-(furan-2-yl)-1H-pyrrole-2-carboxylate is used as a chemical intermediate for [application reason] in the chemical industry. The presence of the carboxylate ester and amino groups in its structure suggests that it may be involved in the synthesis of more complex molecules or used in reactions that require these functional groups.
Used in Chemical Synthesis:
Ethyl 3-amino-5-(furan-2-yl)-1H-pyrrole-2-carboxylate is used as a building block for the synthesis of more complex organic compounds, particularly in the pharmaceutical and agrochemical industries. Its reactivity and the presence of functional groups make it a valuable component in the creation of new molecules with potential applications in these fields.
Used in Research Applications:
Ethyl 3-amino-5-(furan-2-yl)-1H-pyrrole-2-carboxylate is used as a research compound for studying the properties and reactions of heterocyclic aromatic compounds. Its unique structure and potential reactivity provide opportunities for researchers to explore new chemical pathways and mechanisms, contributing to the advancement of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 237435-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,7,4,3 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 237435-96:
(8*2)+(7*3)+(6*7)+(5*4)+(4*3)+(3*5)+(2*9)+(1*6)=150
150 % 10 = 0
So 237435-96-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2O3/c1-2-15-11(14)10-7(12)6-8(13-10)9-4-3-5-16-9/h3-6,13H,2,12H2,1H3
237435-96-0Relevant articles and documents
FUSED HETEROCYCLIC COMPOUND
-
Page/Page column 142, (2008/06/13)
The present invention relates to a compound represented by the formula: wherein W is C(R 1 ) or N, each A is an optionally substituted aryl group or a heteroaryl group, X 1 is -NR 3 -Y 1 -, -O-, -S-, -SO-, -SO 2 or -CHR 3 - wherein R 3 is a hydrogen atom or an optionally substituted aliphatic hydrocarbon group, or R 3 is optionally bonded to A to form an optionally substituted ring structure, R 1 is a hydrogen atom or an optionally substituted group bonded via a carbon atom, a nitrogen atom or an oxygen atom, R 2 is a hydrogen atom or optionally substituted group bonded via a carbon atom or a sulfur atom, or R 1 and R 2 , or R 2 and R 3 are optionally bonded to form an optionally substituted ring structure, or a salt thereof, and a tyrosine kinase inhibitor or an agent for the prophylaxis or treatment of cancer, which contains this compound or a prodrug thereof.
Compounds and methods which modulate feeding behavior and related diseases
-
, (2008/06/13)
There are provided compounds, compositions and methods of use thereof in the modulation of feeding behavior, obesity, diabetes, cancer (tumor), inflammatory disorders, depression, stress related disorders, Alzheimer's disease and other disease conditions.